Jamunarani Veeraraghavan

Author

Baylor College of Medicine ORCID

Also Known As

J Veeraraghavan, J. Veeraraghavan, Jamunarani VEERARAGHAVAN, Jamunarani Veeraraghavan, Veeraraghavan, Jamunarani

191

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Baylor College of Medicine University of Oklahoma Health Sciences Center The University of Texas Health Science Center at San Antonio Dana-Farber Cancer Institute University of Oklahoma

About

Jamunarani Veeraraghavan is an author at Baylor College of Medicine specializing in medicine, radiation oncology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	276
2	Cell Biology	4	4	114
3	Engineering	1	1	11
4	Health Sciences	1	1	46
5	Cellular Physiology	1	1	41

Jamunarani Veeraraghavan

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer Xiaoyong Fu, Resel Pereira, Carmine De Angelis, Proceedings of the National Academy of Sciences	2019	164
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade Aleix Prat, Tomás Pascual, Carmine De Angelis, JNCI Journal of the National Cancer Institute	2019	163
Recurrent ESR1–CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers Jamunarani Veeraraghavan, Ying Tan, Xi-Xi Cao, Nature Communications Breast OncologyMedicineMolecular BiologyAggressive SubsetBreast Cancer	2014	147
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer Xiaowei Xu, Carmine De Angelis, Kathleen A. Burke, Clinical Cancer Research	2017	122
Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer Carmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo, Clinical Cancer Research	2021	91
Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy Carmine De Angelis, Chandandeep Nagi, Cliff C. Hoyt, Clinical Cancer Research	2019	81
Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancers Jinah Kim, Ying Tan, Xian Wang, Nature Communications	2016	72
Radiation-triggered Tumor Necrosis Factor (TNF) α-NFκB Cross-signaling Favors Survival Advantage in Human Neuroblastoma Cells Jamunarani Veeraraghavan, Mohan Natarajan, Sheeja Aravindan, Journal of Biological Chemistry	2011	70
The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance Agostina Nardone, Hazel M. Weir, Oona Delpuech, British Journal of Cancer	2018	63
Impact of Curcumin, Raspberry Extract, and Neem Leaf Extract on Rel Protein-Regulated Cell Death/Radiosensitization in Pancreatic Cancer Cells Jamunarani Veeraraghavan, Mohan Natarajan, Pallavi Lagisetty, Pancreas	2011	62

Page 1